NCT06119009 is a clinical trial of non interventions in Heart Block, sponsored by Chinese PLA General Hospital.

Who is sponsoring NCT06119009?

NCT06119009 is sponsored by Chinese PLA General Hospital.

What drugs are being tested in NCT06119009?

Interventions in NCT06119009: non interventions.

What condition does NCT06119009 study?

NCT06119009 studies Heart Block, Risk Factor.

Is NCT06119009 still recruiting?

NCT06119009 is currently completed. Last updated 7 November 2023.

Last reviewed 2023-11-07 · How we verify

NCT06119009

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

New-onset Heart Blocks After Noncardiac Surgery: a Retrospective Study of More Than 280,000 Patients

Completed Last updated 7 November 2023

What this trial tests

trial testing non interventions in Heart Block in 281,497 participants. Completed in 1 August 2019.

Timeline

1 January 2008

Primary endpoint
1 August 2019

1 August 2019

Quick facts

Lead sponsor	Chinese PLA General Hospital
Status	Completed
Study type	OBSERVATIONAL
Enrollment	281,497
Start date	1 January 2008
Primary completion	1 August 2019
Estimated completion	1 August 2019

Drugs / interventions tested

non interventions

Conditions studied

Heart Block — all drugs for Heart Block →
Risk Factor — all drugs for Risk Factor →

Sponsor

Chinese PLA General Hospital

Who can join

18 and older, any sex, with Heart Block or Risk Factor. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aimed to investigate new-onset heart blocks after noncardiac surgery, identify risk factors, and develop a prediction model.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Postoperative New-Onset Heart Block in Noncardiac Surgery: Model Development, Validation, and Long-Term Prognostic Analysis.
Zhang K, Li H, Sha X, Liu C, et al · · 2026 · PMID 41863520 · DOI 10.1016/j.jacasi.2026.01.018

Verify or expand the search:

Other recruiting trials for Heart Block

Currently open trials in the same condition.

NCT05015660 — Conduction System Pacing With Left Bundle Branch Pacing as Compared to Standard Right Ventricular Pacing · NA · recruiting

Other Chinese PLA General Hospital trials

Trials by the same sponsor.

NCT07294755 — The Impact of Intrapleural Block on Postoperative Pain Caused by Drainage Tubes After Thoracoscopic Surgery · NA · not yet recruiting
NCT07536607 — Predictive Role of Photon Counting Computed Tomography in Acute Coronary Syndrom Patients · not yet recruiting
NCT07489157 — Real-Time End-Tidal Carbon Dioxide Monitoring for Early Warning of Hypoxemia in Painless Gastrointestinal Endoscopy · NA · not yet recruiting
NCT07494981 — Individualized Precision Therapy With Ceftazidime and Avibactam Guided by PK/PD in Geriatric Populations · not yet recruiting
NCT07496008 — Individualized Precision Isavuconazole Therapy Guided by PK/PD Principles for the Geriatric Population · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06119009 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Chinese PLA General Hospital
Last refreshed: 7 November 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06119009.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing